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Summary.-Serum ferritin has been estimated in 125 untreated patients with
Hodgkin's disease. Increasing concentrations are found at each advancing stage of
the disease and high concentrations are found in patients with systemic symptoms.
In all cases this is associated with a low serum Fe concentration and reduced trans-
ferrin saturation. There is no relationship between serum ferritin concentration
and histological type of disease.
The findings are compatible with a non-specific response of the reticuloendothelial
system to malignancy, producing a secondary disorder of Fe metabolism.
FERRITIN has long been recogniized
as an intracellular Fe storage compound,
but its occasional appearance in the
circulation has been noted in some
malignant states. Reissman and Dietrich
(1956), using a relatively crude method,
detected ferritin in serum from 6 patients
with Hodgkin's disease involving the
liver, an observation later confirmed by
Aungst (1968) who found ferritin in the
serum of 30 patients with Hodgkin's
disease. Bieber and Bieber (1973) used
a semiquantitative technique to detect
ferritin and found it in the serum of 44 /0
of 108 patients with Hodgkin's disease
with a particularly high incidence in late-
stage nodular sclerosing disease.
A number of workers have shown that
ferritin from a variety oftumours displays
characteristics similar to that of foetal
liver or placenta on isoelectric focusing
and have suggested that the production of
" carcinofoetal " ferritin may be a
characteristic of malignant tissue (Jacobs
and Worwood, 1975). Eshhar, Order and
Katz (1974) found ferritin to be present
in Hodgkin's tissue but characterization
of the crystallized protein did not show
any differences from normal liver or
spleen ferritin. Despite the absence of
any detailed information regarding ferritin
in Hodgkin's disease it has been suggested
that the serum ferritin concentration may
be used to monitor disease activity. WVe
have attempted to clarify the relationship
between serum ferritin concentration and
the stage and type of Hodgkin's disease
by analysing the results from 125 uni-
treated patients.
MATERIALS AND METHODS
Serum samples were obtained from 125
newly diagnosed patients with untreated
Hodgkin's disease. In all cases but one, a
full staging procedure wit,h laparatomy
was carried out and the extent of the disease
w%as categorized according to the classification
of the Ann Arbour International Convention
(Carbone et al., 1971). Histology of lymph
node biopsies wsas classified according to the
classification of Lukes and Butler (1966) as
modified at Rye (Lukes et al., 1966) and Ann
Arbour (Rappaport et al., 1971). Serum
ferritin concentration wNas estimated by the
method of Jones and Worwood (1975) in all
125 cases, serum Fe concentration was
measured by a modification of the Young &
Hicks (1965) method in 86 cases and trans-
ferrin saturation in 49 cases. Standard
statistical techniques were used (Siegel,
1956).SERUM FERRITIN IN HODGKIN S DISEASE
RESULTS
The clinical and histological character-
istics of the disease process are shown in
Table 1. A complete staging had not
TABLE I. Clinical and Histological
Characteristics in 1 25 Patients with
Hodgkin's disease
Stagintg I
II
III
IV
Not available
No systemic symptoms
Systemic symptoms
Histolog,qy
Mixed cellularity
Nodular sclerosing
Lymphocytes predominant
Lymphocytes depleted
Unclassified
18
30
54
22
1
60
64
43
48
15
10
9
been carried out on one patient and in 9
cases no clear histological classification
was possible. Serum ferritin concentra-
tion, serum Fe concentration and per-
centage transferrin are shown in Table II
in relation to clinical staging and the
presence of systemic symptoms. Two
patients had serum ferritin concentrations
of 10,972 ,ig/l and 16,253 ,tg/l respectively.
These were so far outside either the
normal or pathological range that they
were excluded from the calculations.
Using the Mann-Whitney U-test, there is a
significant increase in mean serum ferritin
concentration with each stage of the
disease (P < 0.05). Both serum Fe con-
centration and transferrin concentration
are lower than normal in patients with
Hodgkin's disease but neither measure-
ment showed a correlation with clinical
stage. The mean serum ferritin con-
centration is more than twice as high in
patients with symptoms of systemic
disease than in those with no symptoms
(P < 0.05).
There was no significant difference in
serum ferritin or Fe concentrations, nor
in transferrin saturation between patients
with different histological types of disease
(Table III). The Mann-Whitney test
gives P > 0 05 for the differences between
any two groups.
DISCUSSION
Our previous studies of patients with
untreated Hodgkin's disease showed that
a low serum Fe concentration associated
with evidence of impaired release of Fe
from the reticuloendothelial (RE) system
was common to all stages (Beamish
et al., 1972). Serum ferritin concentration
is closely related to RE Fe load (Jacobs
and Worwood, 1975) and Jones et al.
(1973) observed that the low serum
TABLE II.-Serum Ferritin, Serum Fe and Transferrin Saturation Related to Clinical
Staging
Serum ferritin
,1lg/l
M\ean
419-8
485-7
602 0
1107-2
A-No systemic symptoms* 334 - 8
B Systemic symptomst 840-3
Normal values
Range
63-2715
25-2238
18-4828
70-7303
35-2715
18-7303
99-3t 1-580
Serum Fe
I-1
Alean
11 3
11-9
11.9
10-3
Range
1 1-29 0
1 4-31 5
3-9-29-5
3-6-26-0
Transferrin
saturation %
Mean Range
13-7 2-26
22- 8 5-56
16-5 6-36
19-0 7-42
12-2 1 1-31-5 16-9
10 8 3 9-29-5 19-2
17-0§ 13 32 26-8§
2-44
6-56
1-80
* Omitting one patient with serum ferritin 10,972 ,g/l.
t Omitting one patient with serum ferritin 16,253 yg/l. I Jacobs and Worwood (1975).
§ Jacobs et al. (1969).
Stage I
II
III*
Ivt
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TABLE III.-Sermrn Ferritin, Serun Fe and Transferrin Saturation Related to Histological
Type of Disease
Sorum forritin
Mean Rainge
Lymphocytes predominaint
Nodular sclerosing*
AMixed cellularity
Lymphoeptes depleted
736- 5
445- 7
536-9
837 8
63-4828
25-4048
18-2524
80-2295
Serum Fe
1111
Mean Range
14 9 3-6-26 5
9-9 1- 1-31-5
11.0 1 4-29(5
11-2 8-5-15-0
Transferriii
satturation %
Mean Range
18-5
17-4 2-56
18-4 5-42
15-ot
* Omitting one patient w%ith serum feiritin 10,972 lig/l.
t One case only.
Fe and transferrini saturation found in
Hodgkin's disease is associated with an
increased concentration of circulating
ferritin. Bieber and Bieber (1973) noted
this increased amount of circulating
ferritin in Hodgkin's disease and referred
to it as a tumour-associated antigen.
Eshhar et al. (1974), while observing
the presence of ferritin in Hodgkin's
tumour tissue, suggested that its presence
in the serum might provide a tool of
bc
9C
8C
a 70
o 6C
0
cn
., 50
a 40
I.-
30
20
10]
potential diagnostic and prognostic im-
portance.
In the present group of patients,
serum ferritin concentration showed a
progressive and significant increase from
Stage I to Stage IV disease (Table II).
In addition, the mean serum ferritin
concentration in patients without systemic
symptoms was less than half that in
symptomatic patients (Table II). How-
ever, a depression of serum Fe concentra-
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FIG. 1.- Serum forritin concentration (log scale) aind transferrin satturation in normal subjects and
patients -with transfusional Fe overload 1 compared with Hodgkin's (lisease patients E.
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Fri(o. 2.-Distribution of seruim ferritini concentration (log scale) in normal women aind patients wvith breast canicer, rheumatoid arthritis and Hodgkin's disease.
tion and transferrin saturation was found
in all stages of the disease as in the
smaller series of Beamish et al. (1972).
Fig. 1 shows the relationship between
serum ferritin and transferrin saturation
in normal subjects and patients with
transfusional Fe overload. In these an
increase in RE storage Fe is associated
with a rise in transferrin saturation. In
comparison, theHodgkin's disease patients
show no increase in transferrin saturation
with increasing ferritin concentration.
All patients with simple Fe overload
who have a serum ferritin above 100 ,ag/l
have a transferrin saturation above 250%.
The majority of Hodgkin's patients with
serum ferritin within this range have a
transferrin saturation below 20%. These
findings are consistent with the operation
of the hypothetical "' RE block " of Fe
release.
In Fig. 2 the distribution of serum
ferritin concentrations in the present
group ofpatients is compared with that of
normal women and those with early breast
cancer (Jacobs et al., 1976) and active
rheumatoid arthritis (Bentley and
Williams, 1974). It is interesting to
note that in both malignant groups many
of the abnormally high levels are similar
to those found in the non-malignant
inflammatory condition. The higher
levels found in some Hodgkin's patients
are usually associated with more ad-
vanced disease and are comparable to
those found by Prieto, Barry and Sherlock
(1975) in patients with a variety of liver
disorders.
The data of Bieber and Bieber (1973)
suggested that ferritinaemia occurred more
commonly in association with certain
histological types of disease. It appeared
to be more common in patients with
nodular sclerosing disease than in those
with a histological picture of mixed
cellularity. Only 3 patients with other
histological types of tumour were
examined. The present data (Table III)
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do not indicate a significant difference
either in serum ferritin or transferrin-
bound Fe concentrations related to
differences in the histology of the tumour
tissue.
The increase in serum ferritin concen-
trations thatwehavefouLnd inpatientswith
Hodgkin's disease appears to be related
to the activity and spread of the tumour.
However, it can be adequately explained
by the non-specific changes known to
occur in the RE cells of all cancer patients
(Cartwright and Lee, 1971) and by the
occurrence of liver damage with release
of hepatocellular ferritin in some cases.
The possibility of abnormal ferritin pro-
duction by the tumour remains, but so
far there is no evidence to support this.
The only instance of increased ferritin
synthesis by malignant cells so far
demonstrated is in the case of acute
myeloblastic leukaemia (White et al.,
1974) and in this condition the serum
levels which result are higher than in the
present series ofpatients.
The empirical value of serum ferritin
estimation in evaluating clinical status or
prognosis in treated patients has not been
assessed, though if it responds as part of a
non-specific reaction to the disease it may
behave very similarly to more con-
ventional, poorly understood indices of
disease activity such as the erythrocyte
sedimentation rate, serum Fe concentra-
tion or plasma protein changes.
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